BioCryst Pharmaceuticals Before Q2 Earnings: How to Play the Stock
BioCryst Pharmaceuticals (BCRX) is preparing to announce its financial results for the second quarter of 2025 on August 4th, prior to the market opening. Analysts predict revenues of approximately $148.85 million for the quarter. Earnings per share (EPS) are projected to be around 3 cents. Analyst Estimates and Trends Recent analyst sentiment has seen some […]
Marco
0 Comments
.
5 hours ago
